Trial Profile
Clinical Trials Insight: 700016464
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 18 Oct 2006
Price :
$35
*
At a glance
- Drugs Perifosine (Primary)
- Indications Cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Keryx Biopharmaceuticals
- 18 Oct 2006 New trial record.